BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18201274)

  • 21. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
    Lee S; Choi EJ; Jin C; Kim DH
    Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
    Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
    Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MNX1 reduces sensitivity to anoikis by activating TrkB in human glioma cells.
    Jiang L; Chen S; Zhao D; Yan J; Chen J; Yang C; Zheng G
    Mol Med Rep; 2018 Sep; 18(3):3271-3279. PubMed ID: 30066929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine receptor kinase B silencing inhibits anoikis‑resistance and improves anticancer efficiency of sorafenib in human renal cancer cells.
    Zhang P; Xing Z; Li X; Song Y; Zhao J; Xiao Y; Xing Y
    Int J Oncol; 2016 Apr; 48(4):1417-25. PubMed ID: 26820170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between the expression of TrkB and anoikis resistance in nasopharyngeal carcinoma line].
    Wen WS; Zhang Z; Xie Y; Yi X; Zhao WM; Xu ZW; Tang AZ; Huang GW
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug; 43(8):606-11. PubMed ID: 18959266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Betulin terpenoid targets OVCAR-3 human ovarian carcinoma cells by inducing mitochondrial mediated apoptosis, G2/M phase cell cycle arrest, inhibition of cell migration and invasion and modulating mTOR/PI3K/AKT signalling pathway.
    Yang Q; Fei Z; Huang C
    Cell Mol Biol (Noisy-le-grand); 2021 Sep; 67(2):14-19. PubMed ID: 34817343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tropomyosin-related kinase B promotes distant metastasis of colorectal cancer through protein kinase B-mediated anoikis suppression and correlates with poor prognosis.
    Fan M; Sun J; Wang W; Fan J; Wang L; Zhang X; Yang A; Wang W; Zhang R; Li J
    Apoptosis; 2014 May; 19(5):860-70. PubMed ID: 24549576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
    Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
    Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.
    Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Kouttab N; Chu W; Wan Y
    Int J Oncol; 2006 Oct; 29(4):1003-11. PubMed ID: 16964397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defect of tropomyosin-related kinase B isotype expression in ovarian clear cell adenocarcinoma.
    Goto Y; Kametani Y; Kikugawa A; Tsuda B; Miyazawa M; Kajiwara H; Terao Y; Takekoshi S; Nakamura N; Takeda S; Mikami M
    Biosci Trends; 2014 Apr; 8(2):93-100. PubMed ID: 24815386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis.
    Smit MA; Peeper DS
    Oncogene; 2011 Sep; 30(35):3735-44. PubMed ID: 21478908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Mar; 30(9):1020-31. PubMed ID: 20972462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TrkB expression level correlates with metastatic properties of L1 mouse sarcoma cells cultured in non-adhesive conditions.
    Miłoszewska J; Przybyszewska M; Gos M; Swoboda P; Trembacz H
    Cell Prolif; 2013 Apr; 46(2):146-52. PubMed ID: 23510469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of E74-Like Factor 5 (ELF5) Inhibits Migration and Invasion of Ovarian Cancer Cells.
    Zhang X; Lin J; Ma Y; Zhao J
    Med Sci Monit; 2019 Jan; 25():856-865. PubMed ID: 30696803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
    Liau SS; Jazag A; Ito K; Whang EE
    Br J Cancer; 2007 Mar; 96(6):993-1000. PubMed ID: 17342093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer.
    Howe EN; Cochrane DR; Cittelly DM; Richer JK
    PLoS One; 2012; 7(11):e49987. PubMed ID: 23185507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.
    Zhu L; Werner JA; Mandic R
    Anticancer Res; 2007; 27(5A):3121-6. PubMed ID: 17970052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.